TBEV NS3

Tick-Borne Encephalitis Virus NS3 Recombinant
Shipped with Ice Packs
In Stock

Description

Overview of TBEV NS3

TBEV NS3 is a multifunctional non-structural protein encoded by the tick-borne encephalitis virus (TBEV), a member of the Flaviviridae family. It plays a central role in viral replication, polyprotein processing, and immune evasion . NS3 comprises two functional domains:

  • N-terminal serine protease: Requires NS2B as a co-factor for cleaving viral polyproteins .

  • C-terminal helicase/ATPase: Involved in RNA unwinding during replication .

NS3 interacts with multiple viral and host proteins, making it critical for viral lifecycle and a potential target for antiviral strategies .

Post-Translational Modifications

  • Phosphorylation: Five conserved phosphorylation sites in NS3 (tick-borne flavivirus-specific) .

  • Acetylation: Modulates interactions with host DNA repair proteins (e.g., Ku70) .

Proteolytic Activity

NS3, with NS2B, processes the viral polyprotein into functional subunits. Mutations near the protease domain alter viral neuroinvasiveness .

Helicase/NTPase Activity

The helicase domain unwinds viral RNA, facilitating replication. ATPase activity is critical for RNA synthesis .

Immunomodulatory Functions

  • Induces degradation of host antiviral protein viperin via proteasome-dependent pathways .

  • Suppresses DNA damage response (DDR) by inhibiting SIRT1-mediated deacetylation of Ku70 and KAP1, impairing nonhomologous end joining (NHEJ) .

Interaction with Host Proteins

Host ProteinEffect on TBEVMechanism
ViperinRestricts TBEV replicationPromotes proteasomal degradation of NS3
SIRT1Enhances viral replicationNS5-NS3 interaction inhibits SIRT1 activity
90S pre-ribosomeModulates ribosomal biogenesisNS3-UTP20 interaction reduces rRNA synthesis

Autophagy Regulation

  • TBEV NS3 (with NS2B) induces autophagy but blocks autolysosome formation, promoting viral persistence .

Genetic Variability of NS3

Phylogenetic analysis of NS3 sequences from Lithuanian TBEV strains revealed:

  • Nucleotide identity: 95.5–100% (divergence 0–4.5%) .

  • Regional diversity: Clustering by geographic location rather than tick species .

Vaccine Development Challenges

Despite NS3’s immunogenicity, experimental vaccines targeting NS3 show limited efficacy:

StudyVaccine PlatformOutcome
MVA-NS3 (C57BL/6 mice)Recombinant vacciniaInduced NS3-specific T cells but no protection
DNA vaccine (mice)NS3 plasmidPartial protection against DENV, not TBEV

NS3-specific T cells are detectable in TBE patients but are insufficient for standalone protection .

Research Gaps and Future Directions

  • Structural insights: NS3-NS5 interaction dynamics remain poorly characterized .

  • Therapeutic targeting: Conserved PTMs (e.g., phosphorylation) may enable broad-spectrum antivirals .

  • Vaccine design: NS3’s helicase domain may require adjuvant co-delivery to enhance efficacy .

Product Specs

Introduction
Tick-borne encephalitis (TBE) is caused by the tick-borne encephalitis virus (TBEV), a member of the Flaviviridae family. A closely related virus found in Far Eastern Eurasia is the Russian spring-summer encephalitis virus (RSSEV). The Flaviviridae family also includes other tick-borne viruses closely related to TBEV and RSSEV, such as the Omsk hemorrhagic fever virus and Kyasanur Forest virus. Louping ill virus is also a member of this family.
Description
This recombinant protein, derived from E. coli, contains epitopes of the Tick-borne Encephalitis Virus NS3 protein.
Purity
The purity of the Encephalitis protein is greater than 95%, as determined by 10% PAGE (coomassie staining).
Formulation
The protein is formulated in a solution of 20mM MES (pH 6.5), 8M urea, 200mM NaCl, and 0.05% Tween-20.
Stability
For optimal stability, the Encephalitis protein should be stored below -18°C. While it can remain stable at 4°C for up to one week, repeated freeze-thaw cycles should be avoided.
Applications
The Encephalitis antigen is suitable for use in ELISA and Western blots. It serves as an excellent antigen for the detection of Tick-borne encephalitis virus with minimal specificity issues.
Source
Escherichia Coli.
Purification Method
Encephalitis protein was purified by proprietary chromatographic technique.
Specificity
Immunoreactive with sera of encephalitis virus infected individuals.

Q&A

What is the high-resolution structure of TBEV NS3 helicase and how does it compare to other flavivirus helicases?

The crystal structure of TBEV NS3 helicase has been determined to a resolution of 2.14 Å, revealing key atomic-level features that are essential for its function . The structure consists of three domains with specific functional roles in nucleotide binding and RNA interaction. Alignment with homologous structures shows that the NTP binding site and RNA-binding sites are located in motifs II and VI of NS3, with critical binding residues conserved across species in the genus .

While TBEV NS3 shares significant structural homology with other flavivirus helicases, it demonstrates distinct conformational transitions. Compared to West Nile Virus (WNV) NS3 helicase, TBEV NS3 shares only 49% sequence identity, which is lower than that of dengue virus (DENV) or Zika virus (ZIKV) . These structural differences may account for virus-specific functional characteristics and represent potential targets for selective antiviral development.

How do the functional domains of TBEV NS3 coordinate during viral replication?

TBEV NS3 contains two principal functional domains: a serine protease at the N-terminus and a helicase domain at the C-terminus. The helicase domain exhibits three essential enzymatic activities: RNA unwinding, nucleoside triphosphatase (NTPase) activity, and RNA 5'-triphosphatase (RTPase) activity . These activities work in concert during viral replication.

The coordination between these domains involves both intramolecular and intermolecular interactions. Molecular dynamics simulations have revealed a sophisticated coupling between the RNA binding groove and the ATPase site of NS3 helicase . This coupling ensures that ATP hydrolysis is efficiently translated into mechanical force for RNA unwinding. Additionally, NS3 interacts with other viral proteins, notably NS5, which contains an RNA-dependent RNA polymerase (RdRp) domain, forming a functional replication complex .

What is the current model for ATP-driven RNA translocation by TBEV NS3 helicase?

The current model for ATP-driven RNA translocation by TBEV NS3 helicase involves a cyclical process of nucleotide binding, hydrolysis, and product release. After ATP binding, the protein favors hydrolysis, followed by favoring ATP binding for the next cycle after the release of products . This cycle drives conformational changes that translate into directional movement along the RNA substrate.

Crystal structures and molecular dynamics simulations suggest that the Motif-VI loop acts as a nucleotide valve, regulating the affinity of the protein for different nucleotide states throughout the hydrolysis cycle . Specifically, in TBEV NS3, Arg461 (equivalent to Arg463 in other flaviviruses) switches from direct contact with the phosphate moiety in ATP-bound states to water-mediated contact in ADP-bound states. Similarly, Arg464 becomes detached from ADP in the ADP-bound form . These structural changes modulate nucleotide affinity and ensure unidirectional progression of the helicase along RNA.

How does the phosphate release pathway in TBEV NS3 helicase influence its enzymatic activity?

The phosphate release pathway in TBEV NS3 helicase plays a crucial role in the ATP hydrolysis cycle and ultimately affects RNA translocation. Molecular dynamics simulations have revealed specific residues and conformational changes involved in this process . Following ATP hydrolysis, the inorganic phosphate must be released from the active site to allow the cycle to continue.

The pathway for phosphate release involves a series of coordinated movements of key residues in the active site. Research has identified a mechanistic hypothesis where specific residues facilitate the movement of the phosphate from its binding site toward the protein surface . Site-directed mutagenesis experiments have validated this model, showing that mutations of residues along this pathway significantly affect ATPase activity and consequently RNA unwinding efficiency .

What is known about the interaction between TBEV NS3 and NS5, and how can this be characterized experimentally?

The interaction between TBEV NS3 and NS5 is critical for viral replication as these proteins work together in the replication complex. This interaction has been validated using multiple techniques including ELISA, surface plasmon resonance, and pull-down experiments . NS3 is the only known anchor of NS5 to the endoplasmic reticulum membrane, where viral replication occurs .

To characterize this interaction experimentally, researchers have employed hydrogen-deuterium exchange mass spectrometry (HDX-MS) coupled with high ambiguity driven protein-protein docking approaches . This combination allows for the identification of interaction interfaces and provides constraints for computational modeling. Additionally, homology modeling of the NS5 RNA-dependent RNA polymerase (RdRp) followed by molecular dynamics equilibration has been used to generate starting structures for interaction studies .

The complex formation between NS3 and NS5 facilitates coordinated RNA unwinding and synthesis during replication. Understanding the precise nature of this interaction could provide targets for antiviral development that disrupt the replication complex.

How do host factors influence TBEV NS3 function in infection?

The immunological response to TBEV infection also affects viral replication and disease progression. Studies have shown that TBEV-specific T-cell responses to viral proteins, including non-structural proteins like NS3, NS1, and NS5, are significantly lower in patients with severe acute illness compared to patients with mild tick-borne encephalitis (TBE) . Lower T-cell responses to these proteins correlate with the development of meningoencephalomyelitis, suggesting that virus-specific T cells provide a degree of protection against severe TBEV-induced disease .

What computational approaches are most effective for predicting TBEV NS3-RNA interactions?

Several computational approaches have proven effective for studying TBEV NS3-RNA interactions:

  • Homology Modeling: This technique has been successfully applied to build models of TBEV NS3 domains based on known structures of related flavivirus proteins . These models provide a foundation for further computational analyses.

  • Molecular Dynamics Simulations: These simulations model the physical movements of atoms and molecules over time, providing insights into the dynamic behavior of NS3-RNA complexes . They are particularly valuable for understanding conformational changes during the catalytic cycle.

  • High Ambiguity Driven Protein-Protein Docking: This approach can be adapted to study protein-nucleic acid interactions by incorporating experimental constraints such as those from hydrogen-deuterium exchange mass spectrometry .

The effectiveness of these methods depends on the quality of the starting structures and the accuracy of the force fields used. For TBEV NS3-RNA interactions, combining structural data from crystallography with molecular dynamics simulations has yielded valuable insights into the mechanism of RNA binding and translocation.

What experimental techniques provide the most reliable data on TBEV NS3 helicase activity?

Several experimental techniques have been employed to characterize TBEV NS3 helicase activity with high reliability:

  • X-ray Crystallography: This technique has provided high-resolution structures of TBEV NS3 helicase (2.14 Å), revealing critical details about nucleotide and RNA binding sites . Crystallographic studies of different nucleotide-bound states provide snapshots of the catalytic cycle.

  • Enzymatic Assays on Phosphate Release: These assays directly measure the ATPase activity of NS3 helicase by quantifying inorganic phosphate released during ATP hydrolysis . They provide kinetic parameters that characterize the enzyme's efficiency.

  • Site-Directed Mutagenesis: This approach tests the functional importance of specific residues by introducing targeted mutations and assessing their effects on enzymatic activity . It provides empirical validation of mechanistic hypotheses derived from structural and computational studies.

  • RNA Unwinding Assays: These assays directly measure the helicase's ability to separate double-stranded RNA, providing functional data that complements the biochemical characterization of ATPase activity.

Combining these techniques provides a comprehensive understanding of TBEV NS3 helicase activity, from structural determinants to functional consequences.

What structural features of TBEV NS3 helicase can be exploited for selective inhibitor design?

The crystal structure of TBEV NS3 helicase reveals several potential targets for selective inhibitor design:

  • NTP Binding Site: Located in motifs II and VI of NS3, this site contains conserved residues critical for ATP binding and hydrolysis . While conservation may limit selectivity, subtle structural differences between TBEV and human helicases could be exploited.

  • RNA-Binding Groove: This positively charged channel accommodates the negatively charged RNA backbone. The specific geometry and residue composition of this groove in TBEV NS3 could allow for selective targeting.

  • Allosteric Sites: Regions that undergo conformational changes during the catalytic cycle, such as the Motif-VI loop that functions as a nucleotide valve , present opportunities for allosteric inhibition.

  • Protein-Protein Interaction Interfaces: The interface between NS3 and NS5 or other viral proteins could be targeted to disrupt the replication complex .

The crystal structure determination of TBEV NS3 helicase to 2.14 Å resolution provides atomic-level details that form the basis for rational drug design . Comparative analysis with host helicases can identify features unique to TBEV NS3 that could be exploited for selective inhibition.

How might the characterization of the ATP hydrolysis cycle in TBEV NS3 inform novel therapeutic approaches?

Understanding the ATP hydrolysis cycle in TBEV NS3 provides several avenues for therapeutic intervention:

  • Transition State Analogs: Knowledge of the precise mechanism of ATP hydrolysis allows for the design of transition state analogs that can inhibit the enzyme with high specificity. Structural data on key residues involved in coordination of ATP and its hydrolysis products provide templates for such inhibitors.

  • Disruption of the Phosphate Release Pathway: The characterized phosphate release pathway in NS3 helicase presents a novel target for inhibition. Blocking this pathway would prevent completion of the catalytic cycle and inhibit helicase activity.

  • Targeting the Nucleotide Valve Function: The Motif-VI loop acts as a nucleotide valve, regulating nucleotide affinity throughout the hydrolysis cycle . Compounds that lock this valve in a specific conformation could prevent the cycling necessary for helicase function.

  • Uncoupling Energy Transduction: The coupling between ATP hydrolysis and RNA translocation is essential for helicase function. Compounds that disrupt this coupling would allow ATP hydrolysis to continue without productive RNA unwinding, effectively neutralizing the helicase.

How does the T-cell response to TBEV NS3 correlate with disease severity and outcomes?

Research has shown that TBEV-specific T-cell responses to viral proteins, including non-structural proteins like NS3, correlate significantly with disease outcomes. Studies on TBE patients have revealed that virus-specific T-cell responses to NS5 and other non-structural proteins are significantly lower in patients with severe acute illness compared to those with mild TBE . Lower T-cell responses also correlate with the development of meningoencephalomyelitis .

These findings suggest that virus-specific T cells provide a certain degree of protection against severe TBEV-induced disease. The magnitude of virus-specific T-cell responses early after TBEV infection inversely correlates with the risk of developing more severe neurological manifestations . This has important implications for understanding the pathogenesis of TBEV infection and for developing immunotherapeutic approaches.

While the search results do not provide specific data on T-cell epitopes within NS3, the correlation between T-cell responses to non-structural proteins and disease outcomes suggests that NS3-specific T-cell responses may play a protective role. Further research to identify immunodominant epitopes within NS3 could inform vaccine development and immunotherapeutic strategies.

What methodological approaches can be used to study the immunological aspects of TBEV NS3?

Several methodological approaches can be employed to study the immunological aspects of TBEV NS3:

  • Ex Vivo T-Cell Assays: Peripheral blood mononuclear cells (PBMCs) from TBEV-infected patients can be stimulated with NS3 peptides to measure specific T-cell responses. Techniques such as ELISpot, intracellular cytokine staining, and proliferation assays can quantify these responses .

  • Epitope Mapping: Overlapping peptide libraries covering the NS3 sequence can be used to identify specific epitopes recognized by T cells from infected individuals. This information is valuable for understanding the immunodominance hierarchy and for vaccine design.

  • HLA Tetramer Analysis: For known epitopes, HLA tetramers can be used to directly identify and characterize NS3-specific T cells without requiring functional responses.

  • Longitudinal Studies: Following T-cell responses to NS3 and other viral proteins over time in infected individuals can provide insights into the dynamics of the immune response and its correlation with disease progression and resolution .

  • Animal Models: Humanized mouse models or other animal models of TBEV infection can be used to study the role of NS3-specific T cells in protection and pathogenesis under controlled conditions.

These approaches can help elucidate the role of NS3-specific immune responses in protection against TBEV infection and inform the development of vaccines and immunotherapeutics.

What are the current gaps in our understanding of TBEV NS3 function and structure?

Despite significant advances, several important gaps remain in our understanding of TBEV NS3:

  • Complete Structural Characterization: While the crystal structure of TBEV NS3 helicase has been determined , structures of the full-length NS3 (including the protease domain) in complex with RNA and other viral proteins are lacking. Such structures would provide insights into the coordinated function of different domains.

  • Mechanistic Details of RNA Translocation: The precise mechanism by which ATP hydrolysis is translated into directional movement along RNA requires further elucidation. Capturing intermediate states in this process remains challenging.

  • Regulatory Mechanisms: How the activity of NS3 is regulated within the replication complex and in response to cellular conditions is not fully understood. Post-translational modifications and allosteric regulations may play important roles.

  • Strain-Specific Differences: Variations in NS3 sequences between different TBEV strains may contribute to differences in virulence and pathogenicity. Comparative studies of NS3 from different strains are needed to address this question.

  • Host-Specific Interactions: The complete network of host factors that interact with NS3 and modulate its function remains to be fully characterized. Identifying these factors could reveal new therapeutic targets.

What innovative experimental approaches could advance our understanding of TBEV NS3 helicase mechanisms?

Several innovative experimental approaches could significantly advance our understanding of TBEV NS3 helicase mechanisms:

  • Time-Resolved Structural Methods: Techniques such as time-resolved X-ray crystallography, cryo-electron microscopy with millisecond freezing, or serial femtosecond crystallography could capture intermediate states during the catalytic cycle of NS3 helicase.

  • Single-Molecule Techniques: Approaches such as single-molecule FRET or optical tweezers could provide real-time observations of individual NS3 molecules as they translocate along RNA, offering insights into the mechanistic details that are obscured in ensemble measurements.

  • In-Cell Structural Biology: Techniques that allow structural characterization of proteins within their native cellular environment, such as in-cell NMR or cryo-electron tomography, could reveal how the cellular context influences NS3 structure and function.

  • Integration of Computational and Experimental Approaches: Combining molecular dynamics simulations with experimental validation using site-directed mutagenesis and functional assays can provide a more comprehensive understanding of NS3 mechanisms .

  • Systems Biology Approaches: Comprehensive analysis of the NS3 interactome, coupled with functional genomics screens, could identify new host factors that modulate NS3 function and reveal potential therapeutic targets.

Product Science Overview

Introduction

Tick-Borne Encephalitis Virus (TBEV) is a significant pathogen that causes Tick-Borne Encephalitis (TBE), a severe neurological disease. TBEV belongs to the Flavivirus genus within the Flaviviridae family. The virus is primarily transmitted through tick bites, and it can lead to a range of symptoms from mild flu-like illness to severe encephalitis. The non-structural protein 3 (NS3) of TBEV plays a crucial role in the virus’s life cycle, making it a target for research and potential vaccine development.

Structure and Function of NS3

The NS3 protein of TBEV is a multifunctional enzyme with protease, helicase, and RNA triphosphatase activities. It is involved in the processing of the viral polyprotein and in the replication of the viral RNA. The NS3 protein is composed of two domains: the N-terminal protease domain and the C-terminal helicase domain. The protease domain is responsible for cleaving the viral polyprotein into functional units, while the helicase domain unwinds the viral RNA, facilitating replication.

Recombinant NS3 Protein

Recombinant NS3 protein refers to the NS3 protein that has been produced through recombinant DNA technology. This involves inserting the gene encoding the NS3 protein into an expression vector, which is then introduced into a host cell (such as E. coli) to produce the protein. The recombinant NS3 protein can be purified and used for various research purposes, including studying the protein’s structure and function, developing diagnostic tools, and exploring its potential as a vaccine target.

Research and Applications

Research on the recombinant NS3 protein of TBEV has provided valuable insights into the virus’s replication mechanisms and potential strategies for intervention. For instance, studies have shown that the NS3 protein is essential for viral replication and that it induces specific immune responses, particularly T cell responses . However, it has also been observed that immunity to the NS3 protein alone may not be sufficient to protect against TBEV infection .

In vaccine development, recombinant NS3 protein has been evaluated as a potential target. A study involving a recombinant Modified Vaccinia Virus Ankara (MVA) expressing the TBEV NS3 gene (MVA-NS3) demonstrated that while the vaccine induced NS3-specific immune responses, it did not provide protection against a lethal dose of TBEV in mice . This suggests that NS3-specific immunity may need to be combined with other viral antigens to achieve effective protection.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.